Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
35
pubmed:dateCreated
2001-8-27
pubmed:abstractText
During the use of tetrapeptide and other proprietary caspase inhibitors in the study of neurodegeneration, we had concluded that mechanisms other than the inhibition of caspases contributed to the protective effects of certain caspase inhibitors. Here we report our studies to identify a target for and hence a mechanism by which the tetrapeptide inhibitor tyrosine-valine-alanine-aspartate-chloromethyl ketone (Ac-YVAD-cmk) is able to rescue neuronal cell cultures from cell death. Ac-YVAD-cmk rescued neuronal cells from cell death in response to oxidative stress and oxygen/glucose deprivation. Affinity labeling with biotinylated YVAD-cmk demonstrated distinct binding proteins for the inhibitor in cells from the central nervous system versus Jurkat cells. Binding to the novel target protein was displaced by class-specific protease inhibitors and suggested that the target is a cysteine protease. Affinity purification and sequencing identified the target as cathepsin-B. Cathepsin-B inhibitors competed with biotinylated YVAD-cmk for the target protein. The availability of the target for binding was reduced in cells that had been rescued by unlabeled inhibitor. Cathepsin-B inhibitors rescue hippocampal slices from cell death induced by oxygen/glucose deprivation. These data provide evidence to support a role for cathepsin-B in neuronal cell death, particularly that following ischemia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
31
pubmed:volume
276
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
32750-5
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11427531-Amino Acid Chloromethyl Ketones, pubmed-meshheading:11427531-Animals, pubmed-meshheading:11427531-Astrocytes, pubmed-meshheading:11427531-Binding Sites, pubmed-meshheading:11427531-Caspases, pubmed-meshheading:11427531-Cathepsin B, pubmed-meshheading:11427531-Cell Death, pubmed-meshheading:11427531-Cell Line, pubmed-meshheading:11427531-Cell Survival, pubmed-meshheading:11427531-Cells, Cultured, pubmed-meshheading:11427531-Cerebellum, pubmed-meshheading:11427531-Cysteine Proteinase Inhibitors, pubmed-meshheading:11427531-Glutamic Acid, pubmed-meshheading:11427531-Hippocampus, pubmed-meshheading:11427531-Mice, pubmed-meshheading:11427531-Neurons, pubmed-meshheading:11427531-Neuroprotective Agents, pubmed-meshheading:11427531-Organ Culture Techniques, pubmed-meshheading:11427531-Rats
pubmed:year
2001
pubmed:articleTitle
Evidence that inhibition of cathepsin-B contributes to the neuroprotective properties of caspase inhibitor Tyr-Val-Ala-Asp-chloromethyl ketone.
pubmed:affiliation
Neuroscience Research, GlaxoSmithKline, Third Avenue, Harlow CM19 5AW, United Kingdom.
pubmed:publicationType
Journal Article, In Vitro